Home › NDC Lookup › RxCUI directory › RxCUI 1300801

24 HR mirabegron 50 MG Extended Release Oral Tablet — RxCUI 1300801

RxNorm drug concept · Semantic clinical drug
RxCUI 1300801 Semantic clinical drug · SCD ● Current RxNorm concept 17 FDA products 35 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1300801
Official name24 HR mirabegron 50 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmirabegron 50 MG 24HR Extended Release Oral Tablet
FDA products mapped17
Package NDCs mapped35
Reported Medicaid activity (SDUD)293,458 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mirabegron: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Mirabegron helps your bladder muscle relax so it can hold more urine before you feel a sudden urge to go. If you're dealing with overactive bladder — the urgency, the leaks, the co...
  • What is mirabegron actually supposed to do for me?
  • For adults taking the tablet, it doesn't matter — you can take it with or without food. But if a child is taking either the tablet or the oral suspension (granules), it should alwa...
  • Does it matter if I take it with food or on an empty stomach?
📖 Read our full Mirabegron guide →

🕸️ Concept Web — How 24 HR mirabegron 50 MG Extended Release Oral Tab... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR mirabegron 50 MG Extended Release Oral Tablet RxCUI 1300801

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Mirabegron 1300786
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Myrbetriq 1300792
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mirabegron Extended Release Oral Tablet 1300790
    • Mirabegron Oral Product 1300788
    • Mirabegron Pill 1300789
    • Mirabegron Extended Release Oral Tablet [Myrbetriq] 1300794
    • Myrbetriq Oral Product 1300795
    • Myrbetriq Pill 1300796
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Mirabegron 50 MG SCDC · 1300800
  • Mirabegron Extended Release Oral Tablet SCDF · 1300790
  • Mirabegron Oral Product SCDG · 1300788
  • Mirabegron Pill SCDG · 1300789

Brand-Name Concepts

📦 FDA Products & Package NDCs

17 products · 35 package NDCs
35 package NDCs map to RxCUI 1300801 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00469-2601-07 4 CARTON in 1 TRAY (0469-2601-07) / 1 BLISTER PACK in 1 CAR... Myrbetriq Astellas Pharma US, Inc. 2012-06-28
00469-2601-30 1 BOTTLE in 1 CARTON (0469-2601-30) / 30 TABLET, FILM COATE... Myrbetriq Astellas Pharma US, Inc. 2012-06-28
00469-2601-90 1 BOTTLE in 1 CARTON (0469-2601-90) / 90 TABLET, FILM COATE... Myrbetriq Astellas Pharma US, Inc. 2012-06-28
00469-2602-07 4 CARTON in 1 TRAY (0469-2602-07) / 1 BLISTER PACK in 1 CAR... Myrbetriq Astellas Pharma US, Inc. 2012-06-28
00469-2602-30 1 BOTTLE in 1 CARTON (0469-2602-30) / 30 TABLET, FILM COATE... Myrbetriq Astellas Pharma US, Inc. 2012-06-28
00469-2602-90 1 BOTTLE in 1 CARTON (0469-2602-90) / 90 TABLET, FILM COATE... Myrbetriq Astellas Pharma US, Inc. 2012-06-28
00469-5020-99 1 BOTTLE in 1 CARTON (0469-5020-99) / 100 mL in 1 BOTTLE Myrbetriq Astellas Pharma US, Inc. 2021-03-25
67184-0571-01 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-... Mirabegron Qilu Pharmaceutical Co., Ltd. 2025-06-30
67184-0571-02 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-... Mirabegron Qilu Pharmaceutical Co., Ltd. 2025-06-30
67184-0572-01 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-... Mirabgeorn Qilu Pharmaceutical Co., Ltd. 2025-06-30
67184-0572-02 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-... Mirabgeorn Qilu Pharmaceutical Co., Ltd. 2025-06-30
68180-0151-06 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-... MIRABEGRON Lupin Pharmaceuticals, Inc. 2024-04-19
68180-0151-09 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-... MIRABEGRON Lupin Pharmaceuticals, Inc. 2024-04-19
68180-0152-06 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-... MIRABEGRON Lupin Pharmaceuticals, Inc. 2024-09-03
68180-0152-09 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-... MIRABEGRON Lupin Pharmaceuticals, Inc. 2024-09-03
69238-2860-01 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-... Mirabegron Amneal Pharmaceuticals NY LLC 2026-04-19
69238-2860-02 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-... Mirabegron Amneal Pharmaceuticals NY LLC 2026-04-19
69238-2861-01 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-... Mirabegron Amneal Pharmaceuticals NY LLC 2026-04-19
69238-2861-02 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-... Mirabegron Amneal Pharmaceuticals NY LLC 2026-04-19
70518-4304-00 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4304... Mirabegron REMEDYREPACK INC. 2025-03-07
70518-4665-00 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... MIRABEGRON REMEDYREPACK INC. 2026-05-22
70710-1159-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-1) Mirabegron Zydus Pharmaceuticals (USA) Inc. 2024-01-23
70710-1159-03 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-3) Mirabegron Zydus Pharmaceuticals (USA) Inc. 2024-01-23
70710-1159-09 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-9) Mirabegron Zydus Pharmaceuticals (USA) Inc. 2024-01-23
70710-1160-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-1) Mirabegron Zydus Pharmaceuticals (USA) Inc. 2024-01-23
70710-1160-03 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-3) Mirabegron Zydus Pharmaceuticals (USA) Inc. 2024-01-23
70710-1160-09 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-9) Mirabegron Zydus Pharmaceuticals (USA) Inc. 2024-01-23
70771-1752-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-1) Mirabegron Zydus Lifesciences Limited 2024-01-23
70771-1752-03 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-3) Mirabegron Zydus Lifesciences Limited 2024-01-23
70771-1752-09 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-9) Mirabegron Zydus Lifesciences Limited 2024-01-23
70771-1753-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-1) Mirabegron Zydus Lifesciences Limited 2024-01-23
70771-1753-03 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-3) Mirabegron Zydus Lifesciences Limited 2024-01-23
70771-1753-09 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-9) Mirabegron Zydus Lifesciences Limited 2024-01-23
71335-2808-01 1 BOTTLE in 1 CARTON (71335-2808-1) / 30 TABLET, FILM COATE... MIRABEGRON Bryant Ranch Prepack 2025-09-26
71335-2810-01 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-... MIRABEGRON Bryant Ranch Prepack 2025-09-26
Observed labelers: Astellas Pharma US, Inc. (7) · Zydus Lifesciences Limited (6) · Zydus Pharmaceuticals (USA) Inc. (6) · Amneal Pharmaceuticals NY LLC (4) · Lupin Pharmaceuticals, Inc. (4) · Qilu Pharmaceutical Co., Ltd. (4) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.